CEO Joe Dominguez told investors that “on-grid” or “front-of-the-meter” configurations are becoming more attractive to the ...

Bristol Myers Squibb & Co (NYSE:BMY) on Tuesday released topline results from the Phase 3 ARISE trial evaluating the efficacy and safety of Cobenfy (xanomeline and trospium chloride) as an ...

Two novel peptides derived from Protagonist's proprietary discovery platform are currently in advanced Phase 3 clinical development, with New Drug Application submissions to the FDA potentially in ...

Hyderabad: The team of Cybercrimes PS, Hyderabad City, apprehended three persons accused of selling fake products of registered brand names. The accused have been identified as Nikhil (26), Mohit ...

Additionally, a phase 3 trial evaluating the combination is planned, pending feedback from an FDA end-of-phase 2 meeting. “This is one of the strongest data set ever seen in an all-comer population of ...

Eli Lilly announced Thursday the successful completion of a phase 3 trial of Orforglipron – the first small-molecule GLP-1 that is administered as a once-daily oral pill. The ACHIEVE-1 trial ...

Mark Huffman has been a consumer news reporter for ConsumerAffairs since 2004. He covers real estate, gas prices and the economy and has reported extensively on negative-option sales. He was ...

Emerge is the third Phase 3 study of MM120 ODT, with the Voyage and Panorama studies in GAD already underway. “In our Phase 2b study, MADRS score improvements after a single MM120 100 µg dose ...

PRINCETON, N.J., April 14, 2025--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced the Phase 3 ODYSSEY-HCM trial evaluating Camzyos (mavacamten) for the treatment of adult patients ...

Enriqueta Felip, MD, PhD, discusses the design of the phase 3 3475A-D77 trial evaluating subcutaneous pembrolizumab in metastatic NSCLC. Enriqueta Felip, MD, PhD, the Universitat Autònoma de Barcelona ...

PRINCETON, N.J.--(BUSINESS WIRE)--$BMY #Camzyos--Bristol Myers Squibb (NYSE: BMY) today announced the Phase 3 ODYSSEY-HCM trial evaluating Camzyos (mavacamten) for ...

Department of Chemistry, College of Natural Sciences; Institute for Data Innovation in Science, Seoul National University (SNU), Seoul 08826, Republic of Korea ...